9 month12 on the 3rd, the National Pharmaceutical Project held the 37th meeting of the 4th Board of Directors in Zhuhai. The meeting deliberated and voted on the relevant proposals, listened to the report on the operation and management of the national pharmaceutical project, and the directors and supervisors carefully deliberated and voted on the proposals, and put forward opinions and suggestions on the company's production, operation and reform and development.

During the period, the board of directors and his party conducted field research on the Zhuhai International Health Port Biopharmaceutical Comprehensive Industrial Park, Tomson Beijian Co., Ltd. "Garden Transparent Factory" and Nutrition Exploration Hall.

In Zhuhai International Health Port Park, the board of directors and supervisors carefully listened to the owners of Sinopharm engineering design services opinions and feedback, for the follow-up company industrial park project design services accumulated experience and practices, to promote the design service quality level continued to improve.

Tomson Beijian's "garden-like transparent factory" is the first in China designed by Sinopharm Engineering and produced by full automation.4A in the industrial tourism area, the board of directors and supervisors visited the raw materials and production process in a more transparent and intuitive way around the factory ring corridor. At the Tomson Beijian Nutrition Exploration Hall, the directors and supervisors learned a lot about nutrition and health knowledge in detail, which provided useful guidance for the company to deepen its medical and health fields and expand its health business in the future.

During the investigation and return visit, the board of directors and supervisors also communicated and exchanged with the relevant leaders of BY-Health on the deepening cooperation in the future cooperation mode, intelligent manufacturing, green and transparent factories, etc. Both parties expressed that they will further strengthen exchanges and cooperation, achieve win-win development, and jointly promote the digital and intelligent transformation and upgrading of the pharmaceutical industry.

National Pharmaceutical Engineering board of directors, board of supervisors and management team participated in the research.

(Integrated Office Feed)